Literature DB >> 12797859

Prevention of cervical cancer.

Annabelle Farnsworth1, Heather S Mitchell.   

Abstract

Cervical screening in Australia is a successful public health initiative. Since the introduction of the National Cervical Screening Program in 1991, there has been a significant fall in incidence of and mortality from cervical cancer. Laboratory quality procedures are critical to ensuring optimal outcomes. Laboratory accreditation procedures are being reviewed in line with recent government recommendations. For a sustainable program, cost-containment issues need to be considered; screening interval, management of screen-detected abnormalities, and new technologies are the critical drivers of cost.

Entities:  

Mesh:

Year:  2003        PMID: 12797859     DOI: 10.5694/j.1326-5377.2003.tb05398.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  3 in total

1.  Postpartum HPV Vaccination Rate and Differences in Background Characteristics Between HPV Vaccinated and Unvaccinated Postpartum Women: Strict Monitoring and Follow-Up of Postpartum HPV Vaccination Program.

Authors:  Chung-Yuan Lee; Chih-Jen Tseng; Chi-Chang Chang; Meng-Chih Lee; Shun-Fa Yang
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

2.  Expenditure and resource utilisation for cervical screening in Australia.

Authors:  Jie-Bin Lew; Kirsten Howard; Dorota Gertig; Megan Smith; Mark Clements; Carolyn Nickson; Ju-Fang Shi; Suzanne Dyer; Sarah Lord; Prudence Creighton; Yoon-Jung Kang; Jeffrey Tan; Karen Canfell
Journal:  BMC Health Serv Res       Date:  2012-12-05       Impact factor: 2.655

3.  Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities.

Authors:  Emmanuela Gakidou; Stella Nordhagen; Ziad Obermeyer
Journal:  PLoS Med       Date:  2008-06-17       Impact factor: 11.069

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.